MicroMass Communications, Inc. has been ISO27001 certified. This means that our information security policies, procedures, and standards have been reviewed by an accredited certifying agent and have deemed to be exceptional.

MicroMass was recognized with a PM360 Trailblazers award win in the Interactive Marketing Program category.

MicroMass had a great showing at the MM&M Awards. The agency was recognized as a finalist in the Relationship Marketing category, was an event sponsor, and launched the social media campaign, #FtheList.  

#FtheList is a social media campaign to raise awareness of the importance of self-care.  

PharmaVOICE talked to Group Associate Creative Director, Bonnie Overton, about how behavioral science is addressing some of pharma’s biggest challenges.  

Three MicroMass programs have been shortlisted as a Trailblazer Award Finalist by PM360 Magazine.

Lead Behaviorist, Meredith Terry, discusses and answers common questions around behavioral science.

Group Associate Creative Director, Bonnie Overton, was recognized as one of the distinguished leaders in the life and sciences field.

In a Pharmaphorum spotlight, Senior Behaviorist, Kathy Moriarty writes about the importance of addressing HCPs ingrained beliefs and behaviors.

Senior Strategist, Mark Matthews, highlights the role technology plays in adherence and compliance.

MicroMass was named a finalist in the relationship marketing category.

MicroMass won the Best Behavior award. The award is based on the ability for MicroMass to develop new and effective ways to tap into previously obscure insights.

For the 13th year in a row, MicroMass has been featured in MM&M’s Top 100 Agency Issue.

Overcoming patient-provider dialogue challenges can be tough. MicroMass Lead Behaviorist sheds light on solutions that can bridge the communication gap.

MicroMass has sponsored an eBook with MM&M on the importance of behavioral science in achieving better outcomes.

MicroMass has been shortlisted, and is one of three finalists, for an agency award presented by MM&M.

MicroMass has partnered with Pharma Phorum to produce a Behavioral Science Spotlight.

As part of PharmaVOICE’s patient voice issue, Lead Behaviorist, Andi Weiss offered her thoughts on how pharma can do more to help caregivers.

As part of PharmaVOICE’s patient voice issue, Vice President, Scientific Strategy, Patty Zipfel, offered her thoughts on how pharma can impact drug development by focusing on the patient.

Read the profile for MicroMass Communications, Inc. in the Med Ad News’ agency issue.

MicroMass submitted an entry in MM&M’s #ConvinceMeToVax online contest.

For National High-Five Day, we celebrate our very own Mike Franke. MicroMass conducted a study to determine the frequency of High-Fives from Associate Creative Director, Mike Franke.

MicroMass was honored with a Silver award for its work on Atopic Dermatitis Insider, a disease education website to help caregivers and their teens with atopic dermatitis (eczema).  

MicroMass is presenting it’s shortlisted work to a panel of pharma industry judges at the Eye for Pharma Philadelphia Pitch Day.

Four programs from MicroMass received finalist recognition from the DTC National Advertising Awards.

For #Writers’ Wednesday, we caught up with Associate Creative Director, Kate Schabot. Learn how she takes a moment to switch gears before she steps up to create effective copy.

It’s National Storytelling Week. That’s why we’ve asked our Behavioral Copywriters and Art Directors to share a story that they’ve told through their work, and why it was important for them to share it.

MicroMass was shortlisted for the prestigious eyeforpharma award for Most Valuable Patient Initiative.  

MicroMass program, Asthma Insider, won Gold in the Consumer Website category for the Pharma Choice awards.

ZEJULA My Way Patient Support Program won bronze in the 2018 Pharma Choice Awards in the DTC/DTP category.

MicroMass participated in a live auction where all the proceeds will benefit CORRAL,  a local nonprofit that pairs rescued horses with girls in high-risk situations to provide healing and transformational life change.

Vote for the two MicroMass entries in the PM360 Pharma Choice awards: Consumer Website category and DTC/DTP categories.

MicroMass won Gold in the Digital Health Awards for our work on the Lexicon STRIPES website. Learn more about this evidence-based website designed to help HCPs build skills.

Even though MicroMass was not announced as a winner at the MM&M awards, we are extremely proud of our team.

For World Heart Day, we wanted to share the connection we have with our heart and the hearts of others.

The Writers Block talked to Senior Behavioral Copywriter, Kellie Powell, about her experiences writing for two programs that have received finalist recognition from the PM360 Trailblazer awards.

August 15th is National Relaxation Day, and MicroMass Associate Creative Director, Kim Zdanowicz, a trained Mindfulness educator, shares how Mindfulness can help you to relax and more!

One of our talented senior behavioral copywriters offers his insights on what it was like to write on the account that generated MM&M finalist recognition.

MicroMass was named a finalist for the 2018 MM&M Awards. MicroMass received the recognition in the Use of Relationship Marketing category for its entry: ZEJULA My Way Patient Support.    

For the 12th year in a row, MicroMass was recognized as a top 100 healthcare agency by MM&M.

Read our agency profile in Med Ad News. Each year Med Ad News profiles the top pharmaceutical healthcare agencies.

MicroMass along with agency partners, Snow Companies and Arnold Worldwide, were honored with recognition for Best Marketing Team. The recognition was from the PM360 Elite awards for our work on an account for chronic uncontrolled moderate-to-severe eczema (atopic dermatitis).

MicroMass received Silver in the Best Disease Education category from the DTC Perspectives. The award recognition was part of a team, including Arnold Worldwide, Intouch Solutions, and MicroMass.

Although MicroMass was not named the winner at the Manny Awards, we are grateful for the recognition that our partner, With Change in Mind received as part of their amazing outreach.

April 10 is National Encourage a Young Writer Day and we asked one of our writers what inspired them when they began writing. Turns out, we all got inspired by the origin story of Writer: Margaret West.

Meredith Terry, lead behaviorist, innovation and practice, offered her thoughts on why pharma brands should incorporate behavioral science.

Rob Peters, EVP, Strategy offered his thoughts on how pharma can do more to enhance beyond-the-pill services and why they’re so essential in today’s pharma environment.

The Heart Award is designed to recognize the social responsibilities and cultures that embody a high commitment to philanthropic and social causes.

This award is the 3rd award recognition that About Carcinoid Community has received in 2017.

Arpan Shah, Marketing Director at Lexicon Pharmaceuticals, was named Marketer of the Year at the 9th annual 2017 PM360 Trailblazer Awards.

MicroMass honored with direct to patient and marketer of the year finalist recognition.

Amber Eaton, Vice President, Group Account Director was recognized as a PharmaVOICE 100 recipient.

MicroMass Communications, Inc. was named to the top 100 healthcare agencies for the 11th year in a row.

Nicotrax, a partner of MicroMass Communications, recently concluded its 4-week smoking cessation study.

PM360 has named MicroMass Communications, Inc. as the Self-promotion Pharma Choice Silver winner.

MicroMass was selected for the PM360 Innovation issue. Read more about how MicroMass is striving to meet both the clinical and psychosocial needs of patients.

The MicroMass unbranded campaign for Atopic Dermatitis Insider was recognized as an Award of Excellence winner in the 30th annual Rx Club Awards. Atopic Dermatitis Insider received the honor for Best Integrated Campaign.

MicroMass client, Jennifer Thomas, won Marketer of the Year at the prestigious PM360 Trailblazer Awards held in New York City.

MicroMass was honored with a prestigious PM360 Trailblazer Award for SaxendaCare^®. SaxendaCare^® was the winner in the Persistence/Adherence program category.